|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date11 Dec 1991 |
A Phase IV interventional post approval trial to investigate effectiveness and safety of vericiguat therapy in Indian patients with chronic heart failure with reduced ejection fraction after a worsening heart failure event. - VERINA
A Phase IV interventional post approval trial to assess the safety of intravitreal aflibercept for the treatment of diabetic macular edema (DME) in patients in India. - VISION AF
A Real-World, Prospective, Observational Study to Evaluatethe Safety and Effectiveness of Rivaroxaban (Xarelto®) forPrevention of Stroke and Systemic Embolism in IndianPatients with Non-valvular Atrial Fibrillation (NVAF) - XARIN
100 Clinical Results associated with Bayer Zydus Pharma Pvt Ltd.
0 Patents (Medical) associated with Bayer Zydus Pharma Pvt Ltd.
100 Deals associated with Bayer Zydus Pharma Pvt Ltd.
100 Translational Medicine associated with Bayer Zydus Pharma Pvt Ltd.